Why is it so difficult to use gemtuzumab ozogamicin?

Blood

Volumn 121, Issue 24, 2013, Pages 4813-4814

  Sylvie Castaigne, ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTINEOPLASTIC AGENT; GEMTUZUMAB; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; CONSOLIDATION CHEMOTHERAPY; FEMALE; HUMAN; MALE; MORTALITY; NOTE;

AMINOGLYCOSIDES; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CONSOLIDATION CHEMOTHERAPY; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE;

MLCS; MLOWN;

EID: 84881278016     PISSN: None     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2013-05-498683     Document Type: Note

References (0)